Surface Oncology Announces Filing of IND for CD39 Targeted Antibody Candidate, SRF617, at Inaugural R&D Day

NEXT STORY
Microbix Wins Ontario Business Award
PREV STORY
Global exosomes market is expected to grow with a CAGR of 17.5% over the forecast period from 2019-2025
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

cCARE Wins Jury Trial Against Former CEO/President Dr. Michael J. Moffett

FRESNO, Calif., Feb. 26, 2016 (GLOBE NEWSWIRE) -- A jury in a civil trial ...

author_avatar
NASDAQ Market News

The global blood screening market is projected to reach USD 3.8 billion by 2026 from USD 2.5 billion in 2021, at a CAGR of 8.4%

author_avatar
NASDAQ Market News

Virtual Clinical Day Recap: Outlook Therapeutics Joined by Drs. Mark Humayun and Firas Rahhal to Discuss Need for FDA-Approved Ophthalmic Bevacizumab and Status of ONS-5010

author_avatar
NASDAQ Market News